Literature DB >> 16959378

Reduced plasma membrane surface expression of GLAST mediates decreased glutamate regulation in the aged striatum.

Justin Nickell1, Michael F Salvatore, Francois Pomerleau, Subbu Apparsundaram, Greg A Gerhardt.   

Abstract

Extracellular L-glutamate poses a severe excitotoxic threat to neurons and glia when unregulated, therefore low synaptic levels of this neurotransmitter must be maintained via a rapid and robust transport system. A recent study from our laboratory showed a reduced glutamate uptake rate in the striatum of the aged Fischer 344 (F344) rat, yet the mechanism underlying this phenomenon is unknown. The current study utilized in vivo electrochemical recordings, immunoblotting and biotinylation in young (6 months), late-middle aged (18 months) and aged (24 months) F344 rats to elucidate the potential role that glutamate transporters (GLT-1, GLAST, and EAAC1) may play in this mechanism. Here we show that the time necessary to clear glutamate from the late-middle aged and aged striatum is significantly prolonged in comparison to the young striatum. In addition, an analysis of various sub-regions of the striatum revealed a marked dorsoventral gradient in terms of glutamate clearance times in the aged striatum, a phenomenon which was not present in the striatum of the animals of the remaining age groups. We also found that the decreased glutamate clearance time observed in the late-middle aged and aged rats is not due to a decrease in the production of total transporter protein among these three transporters. Rather, a significant reduction in the amount of GLAST expressed on the plasma membrane surface in the aged animals (approximately 55% when compared to young rats) may contribute to this phenomenon. These age-related alterations in extracellular l-glutamate regulation may be key contributors to the increased susceptibility of the aged brain to excitotoxic insults such as stroke and hypoxia.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16959378     DOI: 10.1016/j.neurobiolaging.2006.07.015

Source DB:  PubMed          Journal:  Neurobiol Aging        ISSN: 0197-4580            Impact factor:   4.673


  24 in total

1.  Ceftriaxone reduces L-dopa-induced dyskinesia severity in 6-hydroxydopamine parkinson's disease model.

Authors:  Tanya Chotibut; Samantha Meadows; Ella A Kasanga; Tamara McInnis; Mark A Cantu; Christopher Bishop; Michael F Salvatore
Journal:  Mov Disord       Date:  2017-06-20       Impact factor: 10.338

2.  Cortical glutamate levels decrease in a non-human primate model of dopamine deficiency.

Authors:  Z Zhang; J E Quintero; X T Fan; F Zhao; Y Ai; A Andersen; P Hardy; F Ling; G A Gerhardt
Journal:  Brain Res       Date:  2014-01-04       Impact factor: 3.252

3.  Acute treatment with doxorubicin affects glutamate neurotransmission in the mouse frontal cortex and hippocampus.

Authors:  Theresa Currier Thomas; Joshua A Beitchman; Francois Pomerleau; Teresa Noel; Paiboon Jungsuwadee; D Allan Butterfield; Daret K St Clair; Mary Vore; Greg A Gerhardt
Journal:  Brain Res       Date:  2017-07-11       Impact factor: 3.252

4.  Real-time monitoring of extracellular adenosine using enzyme-linked microelectrode arrays.

Authors:  Jason M Hinzman; Justin L Gibson; Ryan D Tackla; Mark S Costello; Jason J Burmeister; Jorge E Quintero; Greg A Gerhardt; Jed A Hartings
Journal:  Biosens Bioelectron       Date:  2015-07-07       Impact factor: 10.618

Review 5.  Electrochemical techniques for subsecond neurotransmitter detection in live rodents.

Authors:  Kevin N Hascup; Erin R Hascup
Journal:  Comp Med       Date:  2014-08       Impact factor: 0.982

6.  P301L tau expression affects glutamate release and clearance in the hippocampal trisynaptic pathway.

Authors:  Holly C Hunsberger; Carolyn C Rudy; Seth R Batten; Greg A Gerhardt; Miranda N Reed
Journal:  J Neurochem       Date:  2014-10-31       Impact factor: 5.372

Review 7.  The role of the tripartite glutamatergic synapse in the pathophysiology of Alzheimer's disease.

Authors:  Carolyn C Rudy; Holly C Hunsberger; Daniel S Weitzner; Miranda N Reed
Journal:  Aging Dis       Date:  2015-03-10       Impact factor: 6.745

8.  Using Enzyme-based Biosensors to Measure Tonic and Phasic Glutamate in Alzheimer's Mouse Models.

Authors:  Holly C Hunsberger; Sharay E Setti; Ryan T Heslin; Jorge E Quintero; Greg A Gerhardt; Miranda N Reed
Journal:  J Vis Exp       Date:  2017-05-03       Impact factor: 1.355

9.  Exercise-Mediated Increase in Nigral Tyrosine Hydroxylase Is Accompanied by Increased Nigral GFR-α1 and EAAC1 Expression in Aging Rats.

Authors:  Jennifer C Arnold; Michael F Salvatore
Journal:  ACS Chem Neurosci       Date:  2015-12-08       Impact factor: 4.418

10.  Effect of A(2A) receptor antagonist (SCH 442416) on the mRNA expression of glutamate aspartate transporter and glutamine synthetase in rat retinal Müller cells under hypoxic conditions in vitro.

Authors:  Jun Yu; Xin Huang; Qirong Wu; Jun Wang; Xiaoyan Yu; Peiquan Zhao
Journal:  Exp Ther Med       Date:  2012-02-13       Impact factor: 2.447

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.